These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105. Molecular Histochemistry Identifies Peptidomic Organization and Reorganization Along Striatal Projection Units. Hishimoto A; Nomaru H; Ye K; Nishi A; Lim J; Aguilan JT; Nieves E; Kang G; Angeletti RH; Hiroi N Biol Psychiatry; 2016 Mar; 79(5):415-420. PubMed ID: 26520239 [TBL] [Abstract][Full Text] [Related]
106. Cerebrospinal Fluid Markers of Medium Spiny Neuron Injury in Huntington's Disease. Bang J; Ross CA Mov Disord; 2021 Feb; 36(2):280-282. PubMed ID: 33599006 [No Abstract] [Full Text] [Related]
107. Integrative enrichment analysis of gene expression based on an artificial neuron. Jiang X; Pan W; Chen M; Wang W; Song W; Lin GN BMC Med Genomics; 2021 Aug; 14(Suppl 1):173. PubMed ID: 34433483 [TBL] [Abstract][Full Text] [Related]
108. A ribonuclease-resistant method of in situ hybridization histochemistry in rat brain tissue. Lu W; Chen H; Wolf ME J Neurosci Methods; 1996 Mar; 65(1):69-76. PubMed ID: 8815311 [TBL] [Abstract][Full Text] [Related]
109. Huntington's Disease in Southeastern Indiana. McAtee OB J Indiana State Med Assoc; 1973 Aug; 66(8):713-6. PubMed ID: 4269891 [No Abstract] [Full Text] [Related]
110. Demise of a neuronal population in Huntington's disease and the importance of hyponeuronogenesis. Kremer HP; Kremer GH Clin Neurol Neurosurg; 1992; 94 Suppl():S7-8. PubMed ID: 1320524 [No Abstract] [Full Text] [Related]
115. Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease. II. Optimization of a stereological estimation procedure. Schmitz C; Rüb U; Korr H; Heinsen H Acta Neuropathol; 1999 Jun; 97(6):623-8. PubMed ID: 10378381 [TBL] [Abstract][Full Text] [Related]
116. Properties of a brain-specific protein fraction which absorbs anti-neuronal antibodies in sera from patients with Huntington's disease. Wedege E Cell Mol Biol Incl Cyto Enzymol; 1979; 25(3):207-13. PubMed ID: 161726 [No Abstract] [Full Text] [Related]
117. Huntington's disease: From basic science to therapeutics. Cepeda C; Tong XP CNS Neurosci Ther; 2018 Apr; 24(4):247-249. PubMed ID: 29582586 [No Abstract] [Full Text] [Related]
118. Novel Neuronal Autoantibodies in Huntington's Disease. Endres D; Werden R; Schweizer T; Schröter N; Schiele MA; Nickel K; Fischer M; Domschke K; Urbach H; Meyer PT; Prüss H; Tebartz van Elst L Biol Psychiatry; 2022 Feb; 91(4):e21-e23. PubMed ID: 33722386 [No Abstract] [Full Text] [Related]
119. Emergence of Bruxism after Reducing Left Pallidal Stimulation in a Patient with Huntington's Disease. Richter D; Saft C; Tönges L Mov Disord Clin Pract; 2020 Aug; 7(6):704-705. PubMed ID: 32775521 [No Abstract] [Full Text] [Related]
120. What the law says about PPE responsibility. Cowper A BMJ; 2020 Apr; 369():m1718. PubMed ID: 32354695 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]